You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 22, 2024

Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride and what is the scope of patent protection?

Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride is the generic ingredient in two branded drugs marketed by Haleon Us Holdings and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride has forty-three patent family members in nineteen countries.

One supplier is listed for this compound.

Summary for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride
International Patents:43
US Patents:2
Tradenames:2
Applicants:1
NDAs:2
Finished Product Suppliers / Packagers: 1
DailyMed Link:chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride
Generic Entry Dates for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride*:
Constraining patent/regulatory exclusivity:
Dosage:
SUSPENSION;ORAL
Generic Entry Dates for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride*:
Constraining patent/regulatory exclusivity:
Dosage:
TABLET;ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Pharmacology for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride

US Patents and Regulatory Information for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Haleon Us Holdings CHILDREN'S ADVIL ALLERGY SINUS chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride SUSPENSION;ORAL 021587-001 Feb 24, 2004 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Haleon Us Holdings ADVIL ALLERGY SINUS chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride TABLET;ORAL 021441-001 Dec 19, 2002 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride

Country Patent Number Title Estimated Expiration
Peru 20040973 COMPOSICIONES DE ANTI-HISTAMINICOS, DESCONGESTIVOS Y DROGAS ANTI-INFLAMATORIAS NO ESTEROIDALES ⤷  Try a Trial
European Patent Office 1572206 COMPOSITIONS DE MEDICAMENTS ANTI-INFLAMMATOIRES NON-STEROIDAUX, DECONGESTIONNANTS ET ANTIHISTAMINIQUES (COMPOSITIONS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS DECONGESTANTS AND ANTI-HISTAMINES) ⤷  Try a Trial
Russian Federation 2322262 КОМПОЗИЦИИ НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ЛЕКАРСТВЕННЫХ СРЕДСТВ, ПРОТИВОЗАСТОЙНЫХ СРЕДСТВ И АНТИГИСТАМИНОВ (COMPOSITIONS OF NONSTEROID ANTI-INFLAMMATORY DRUGS, ANTICONGESTIVE AGENTS AND ANTIHISTAMINICS) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.